HBcAg (HBV) (18 - 27)
CAS No. ———
HBcAg (HBV) (18 - 27)( ——— )
Catalog No. M41243 CAS No. ———
HBcAg (HBV) (18 - 27)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHBcAg (HBV) (18 - 27)
-
NoteResearch use only, not for human use.
-
Brief DescriptionHBcAg (HBV) (18 - 27)
-
DescriptionHBcAg (HBV) (18 - 27)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1155.33
-
Molecular FormulaC580H78N10O15
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Nitecapone
Nitecapone is a reversible inhibitor of S-COMT (IC50 values of 300 nM in rat liver).
-
Ligurobustoside N
Ligurobustoside N (compound 2) is an antioxidative glycoside that can be isolated from the Leaves of Ligustrum robustum. Ligurobustoside N shows antioxidant effects and shows inhibition for AAPH induced hemolysis.
-
Hinesol
(-)-Hinesol (Hinesol) is a potent anticancer agent. (-)-Hinesol induces apoptosis and cell cycle arrest at G0/G1 phase. (-)-Hinesol downregulates MEK/ERK pathway and NF-κB pathway and mediates theexpression of cyclin D1, Bax and Bcl-2. (-)-Hinesol has the potential for the research of non–small cell lung cancer.
Cart
sales@molnova.com